Pure Global
NCT06333236

Effect of Kron (Citicoline and Nicotinamide Oral Solution) on Patients With Open-angle Glaucoma

ASST Santi Paolo e Carlo·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Glaucoma
Drug/Device/Intervention
Food for Special Medical Purposes: Kron®
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
ASST Santi Paolo e Carlo
Timeline & enrollment
Phase
N/A
Start date
Mar 25, 2024
End date
Nov 30, 2024
Enrollment
30 participants
Primary outcome

Electrofunctional evaluation

Summary

Aim of this study is to investigate the administration effects of the combination of
 citicoline 40mg/ml and nicotinamide 15mg/ml oral solution (Kron®) on short term improvement
 in inner retinal function, bioelectrical activity of the visual cortex and visual function.

ICD-10 classifications
GlaucomaGlaucomaOther glaucomaGlaucoma, unspecifiedGlaucoma in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06333236
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06333236 through Pure Global AI's free database. This phase not specified trial is sponsored by ASST Santi Paolo e Carlo and is currently Not yet recruiting. The study focuses on Glaucoma. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.